Response by Lytvyn et al to Letter Regarding Article, “Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.